Name
A Pro/Con Debate: Should We Refer to Clinical Trials “as a Care Option”
Date & Time
Tuesday, October 18, 2022, 2:00 PM - 3:30 PM
Location Name
Celebrity 5-8
Description

In this session, two speakers will debate whether the current trend of referring to "clinical trials as a care option" is a positive statement that reinforces that research participants should be offered to all patients as part of medical care or a statement that inappropriately blurs the line between medical care and clinical research, creating a therapeutic misconception. 

Speakers
David Forster - Chief Compliance Officer - WCG
Karla Childers - Head, Bioethics-based Science & Technology Policy - Johnson & Johnson
Maximiliano Elizari - Clinical Research Director - Merck
David Forster Karla Childers Maximiliano Elizari
This Module is Eligible for
ACRP CE Points, CCB Credits, CIP CE Units, CLE Credits, CME Credits, CNE Credits
CIP CEU Credits
1.50
ACRP CE Points
1.50